` SSII (SS Innovations International Inc) vs S&P 500 Comparison - Alpha Spread

SSII
vs
S&P 500

Over the past 12 months, SSII has underperformed S&P 500, delivering a return of -61% compared to S&P 500's +16% growth.

Stocks Performance
SSII vs S&P 500

Loading...
SSII
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
SSII vs S&P 500

Loading...
SSII
S&P 500
Difference
www.alphaspread.com

Performance By Year
SSII vs S&P 500

Loading...
SSII
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
SS Innovations International Inc vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

SS Innovations International Inc
Glance View

Market Cap
534.3m USD
Industry
Health Care

SS Innovations International makes robotic systems for minimally invasive surgery. Its main product is the SSi Mantra surgical robot, which helps surgeons perform procedures with steadier instrument control and better viewing inside the body. The company also supplies the tools, software, and training needed to use the system in operating rooms. Its customers are hospitals, surgical centers, and doctors that want to add robotic surgery capabilities. SS Innovations earns money when it sells or places its robot systems, when customers buy disposable instruments and accessories used in procedures, and when it provides service, maintenance, and training. That gives it a mix of upfront equipment revenue and repeat business from the installed base. What makes its business different is that it sits at the intersection of medical devices and hospital technology. Instead of selling a one-time instrument, it sells a platform that becomes part of the surgical workflow, so adoption depends on surgeon training, clinical trust, and long-term support. The company’s role is to make robotic surgery more accessible to hospitals that want advanced surgical tools without building that technology themselves.

SSII Intrinsic Value
Not Available
Back to Top